Optimizing clinical use of azathioprine with newer pharmacogenetic data.
Wolverton, Stephen E
Optimizing clinical use of azathioprine with newer pharmacogenetic data. [electronic resource] - Archives of dermatology Jun 2009 - 707-10 p. digital
Publication Type: Comment; Editorial
1538-3652
10.1001/archdermatol.2009.95 doi
Azathioprine--adverse effects
Dermatitis, Atopic--drug therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Immunosuppressive Agents--adverse effects
Male
Maximum Tolerated Dose
Pharmacogenetics
Risk Assessment
Sensitivity and Specificity
Skin Diseases, Vesiculobullous--immunology
Vasculitis--drug therapy
Optimizing clinical use of azathioprine with newer pharmacogenetic data. [electronic resource] - Archives of dermatology Jun 2009 - 707-10 p. digital
Publication Type: Comment; Editorial
1538-3652
10.1001/archdermatol.2009.95 doi
Azathioprine--adverse effects
Dermatitis, Atopic--drug therapy
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Immunosuppressive Agents--adverse effects
Male
Maximum Tolerated Dose
Pharmacogenetics
Risk Assessment
Sensitivity and Specificity
Skin Diseases, Vesiculobullous--immunology
Vasculitis--drug therapy